Display options
Share it on

J Thorac Cardiovasc Surg. 2020 Sep 03; doi: 10.1016/j.jtcvs.2020.08.097. Epub 2020 Sep 03.

Ventricular reshaping with a beating heart implant improves pump function in experimental heart failure.

The Journal of thoracic and cardiovascular surgery

Daisuke Onohara, Daniella M Corporan, Takanori Kono, Sandeep Kumar, Robert A Guyton, Muralidhar Padala

Affiliations

  1. Structural Heart Research & Innovation Laboratory, Carlyle Fraser Heart Center, Emory University Hospital Midtown, Atlanta, Ga.
  2. Joint Department of Biomedical Engineering, Emory University/Georgia Institute of Technology, Atlanta, Ga.
  3. Structural Heart Research & Innovation Laboratory, Carlyle Fraser Heart Center, Emory University Hospital Midtown, Atlanta, Ga; Division of Cardiothoracic Surgery, Department of Surgery, Emory University School of Medicine, Atlanta, Ga.
  4. Structural Heart Research & Innovation Laboratory, Carlyle Fraser Heart Center, Emory University Hospital Midtown, Atlanta, Ga; Joint Department of Biomedical Engineering, Emory University/Georgia Institute of Technology, Atlanta, Ga; Division of Cardiothoracic Surgery, Department of Surgery, Emory University School of Medicine, Atlanta, Ga. Electronic address: [email protected].

PMID: 33046233 PMCID: PMC7925703 DOI: 10.1016/j.jtcvs.2020.08.097

Abstract

OBJECTIVE: The left ventricle remodels from an ellipsoidal/conical shape to a spherical shape after a myocardial infarction. The spherical ventricle is inefficient as a pumping chamber, has higher wall stresses, and can lead to congestive heart failure. We sought to investigate if restoring physiological ventricular shape with a beating heart implant improves pump function.

METHODS: Rats were induced with a myocardial infarction, developing left ventricular dilatation and dysfunction, and becoming spherical over 3 weeks. Thereafter, they were randomized to undergo left ventricular reshaping with a beating heart implant (n = 19) or continue follow-up without an implant (n = 19). Biweekly echocardiography was performed until 12 weeks, with half the rats euthanized at 6 weeks and remaining at 12 weeks. At termination, invasive hemodynamic parameters and histopathology were performed.

RESULTS: At 3 weeks after the infarction, rats had a 22% fall in ejection fraction, 31% rise in end diastolic volume, and 23% rise in sphericity. Transventricular implant reshaping reduced the volume by 12.6% and sphericity by 21%, restoring physiologic ventricular shape and wall stress. Over the 12-week follow-up, pump function improved significantly with better ventricular-vascular coupling in the reshaped hearts. In this group, cardiomyocyte cross-section area was higher and the cells were less elongated.

CONCLUSIONS: Reshaping a postinfarction, failing left ventricle to restore its physiological conical shape significantly improves long-term pump function.

Copyright © 2020 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved.

Keywords: adverse remodeling; helical fibers; ischemic cardiomyopathy; sphericity; ventricular shape

References

  1. J Am Med Assoc. 1958 May 31;167(5):557-60 - PubMed
  2. Am J Physiol. 1992 Jul;263(1 Pt 2):H266-70 - PubMed
  3. Eur J Heart Fail. 2012 Jun;14(6):571-80 - PubMed
  4. Eur J Heart Fail. 2001 Jan;3(1):91-6 - PubMed
  5. Arch Mal Coeur Vaiss. 1984 Aug;77(8):953-8 - PubMed
  6. Circ Res. 2016 Sep 30;119(8):944-55 - PubMed
  7. Comp Med. 2016;66(4):290-9 - PubMed
  8. Circulation. 2020 Mar 3;141(9):e139-e596 - PubMed
  9. Science. 2010 Mar 26;327(5973):1653-7 - PubMed
  10. Ann Thorac Surg. 2007 Oct;84(4):1226-35 - PubMed
  11. Thorac Cardiovasc Surg. 1989 Feb;37(1):11-9 - PubMed
  12. Int J Cardiol. 2013 Sep 30;168(2):1186-94 - PubMed
  13. Circ Res. 1980 Nov;47(5):728-41 - PubMed
  14. Int J Comput Assist Radiol Surg. 2019 Aug;14(8):1415-1430 - PubMed
  15. Ann Thorac Surg. 2006 Jan;81(1):42-6 - PubMed
  16. Clin Cardiol. 2000 Nov;23(11):813-9 - PubMed
  17. J Am Soc Echocardiogr. 2003 Feb;16(2):132-9 - PubMed
  18. J Card Surg. 1998 Sep-Oct;13(5):335-42 - PubMed
  19. Cardiovasc Res. 2017 Jun 1;113(7):770-782 - PubMed
  20. Eur J Cardiothorac Surg. 2016 Oct;50(4):693-701 - PubMed
  21. N Engl J Med. 2009 Apr 23;360(17):1705-17 - PubMed
  22. Int J Cardiol. 2014 Feb 15;171(3):368-76 - PubMed
  23. Circ Heart Fail. 2012 May 1;5(3):357-65 - PubMed
  24. Biophys J. 1969 Jul;9(7):954-64 - PubMed
  25. Eur J Cardiothorac Surg. 2006 Apr;29 Suppl 1:S245-50 - PubMed
  26. J Card Surg. 2003 Mar-Apr;18(2):93-100 - PubMed
  27. Mol Cell Biochem. 2020 Jan;463(1-2):33-44 - PubMed
  28. J Am Coll Cardiol. 2010 Dec 7;56(24):1984-93 - PubMed
  29. J Cardiovasc Transl Res. 2017 Aug;10(4):391-400 - PubMed
  30. J Thorac Cardiovasc Surg. 2008 Jan;135(1):188-95 - PubMed

Publication Types

Grant support